Catalyst Pharmaceuticals Inc, rebuked by U.S. Senator Bernie Sanders for its high drug prices, on Thursday defended its $375,000 treatment for a rare disease, saying the price was in line with similar products in the industry.
Sanders, a vocal critic of high drug prices, had written to Florida-based Catalyst earlier this month, asking it to justify its price for Firdapse, a medication for a rare neuromuscular disease that affects about one in 100,000 people in the United States.
Drug pricing has been a major talking point in the United States for the past few years. It was also one of the campaign promises made by President Donald Trump in the 2016 elections, but so far the debate has not resulted in lowering healthcare costs for Americans.
The Trump administration last month proposed a rule to overhaul the industry’s system of rebates, or discounts, while Sanders last month unveiled legislation aimed at lowering drug prices.
For years, patients were able to get Firdapse for free from Jacobus Pharmaceuticals, a small New Jersey-based drug company that offered the drug through a U.S. Food and Drug Administration (FDA) program called “compassionate use.”
The program allows patients with rare diseases and conditions access to drugs not yet approved outside of a clinical trial, when there is no viable alternative.
Catalyst bought the U.S. rights to the drug in 2012 and got approval to sell it in the United States in November last year.
The company said, before its November approval, only about 200 of an estimated 3,000 Lambert-Eaton Myasthenic Syndrome (LEMS) patients in the United States received some form of Firdapse, pointing to a large unmet medical need.
“Now, for the first time, LEMS patients have confidence their therapy is FDA approved and is safe and effective,” Catalyst’s Chief Executive Officer Patrick McEnany said in a letter.
The office of Bernie Sanders, who is seeking the Democratic Party’s presidential nomination in 2020, was not immediately available for comment.
The company said that Firdapse’s price was similar to other products that provide a significant clinical benefit in treating ultra-rare diseases, adding it believed the drug would be widely reimbursed by insurers for the small population it treats.
Physicians can write a prescription where Firdapse will be delivered to a patient’s door and in most cases at an out-of-pocket cost of less than $10 per month, Catalyst said.
Reporting by Manas Mishra and Aakash Jagadeesh Babu in Bengaluru; Editing by Arun Koyyur and Sweta Singh
Trump Twitter-rages at ‘evil propaganda machine’ New York Times
President Donald Trump kicked off his Sunday morning by going on a multi-tweet rant about the New York Times where he blamed them for his poor poll numbers and called them "an evil propaganda machine.'
Trump began with, "The Failing New York Times, in one of the most devastating portrayals of bad journalism in history, got caught by a leaker that they are shifting from their Phony Russian Collusion Narrative (the Mueller Report & his testimony were a total disaster), to a Racism Witch Hunt....., " before adding, "'Journalism' has reached a new low in the history of our Country. It is nothing more than an evil propaganda machine for the Democrat Party. The reporting is so false, biased and evil that it has now become a very sick joke...But the public is aware! #CROOKEDJOURNALISM."
Trump suggests hitting France with 100 percent tariff on wine over dispute with Macron
According to a report from Bloomberg, President Donald Trump publicly suggested that he would consider a 100 percent tariff on wines coming from France.
The report states that the president recently made the suggestion as part of his trade war that has crippled American manufacturers and farmers while at the same time hitting American consumers' wallets.
Trump's comments came during a recent Long Island fundraiser and were tied to his unhappiness with President Emmanuel Macron and his tax on multinational technology companies.
Gun found in FedEx package sent from US to China
Chinese authorities have found at least one firearm in a FedEx package sent from the US, local police said Sunday, in the latest incident to befall the logistics firm in China.
Police in Fuzhou, eastern Fujian province, said "in recent days" they had received a tip about a package sent to a Fujian-based sporting goods company.
The parcel was sent by a US client and contained at least one firearm, said Jin'an district police through their official Twitter-like Weibo account.
The firearm has been seized and officers are investigating, they added, without specifying the number of weapons in the package.